Human Cytomegalovirus (HCMV)-Specific CD4(+) and CD8(+) T Cells Are Both Required for Prevention of HCMV Disease in Seropositive Solid-Organ Transplant Recipients

Documenti analoghi

• Human cytomegalovirus-specific CD4+ and CD8+ T-cells in organ transplant recipients
  di: Lilleri, D., et al.
  Pubblicazione: (2006)
• Sustained impairment of human cytomegalovirus (HCMV)-specific CD4(+ )and CD8(+ )T cell response is responsible for recurrent episodes of disseminated HCMV infection in a D(+)R(- )hand transplant recipient
  di: Baldanti, Fausto, et al.
  Pubblicazione: (2008)
• Prenatal Management of Congenital Human Cytomegalovirus Infection in Seropositive Pregnant Patients Treated with Azathioprine
  di: Cavoretto, Paolo Ivo, et al.
  Pubblicazione: (2020)
• Clinical Significance of Expression of Human Cytomegalovirus pp67 Late Transcript in Heart, Lung, and Bone Marrow Transplant Recipients as Determined by Nucleic Acid Sequence-Based Amplification
  di: Gerna, Giuseppe, et al.
  Pubblicazione: (1999)
• Prenatal Diagnosis of Congenital Human Cytomegalovirus Infection in Amniotic Fluid by Nucleic Acid Sequence-Based Amplification Assay
  di: Revello, M. Grazia, et al.
  Pubblicazione: (2003)